A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1)
Clinical trial NCT05865002 · RECRUITING
Trial details
- NCT number
- NCT05865002
- Sponsor
- Aurigene Discovery Technologies Limited
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-05
- Primary completion
- 2027-01-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.